0001209191-16-148756.txt : 20161107
0001209191-16-148756.hdr.sgml : 20161107
20161107194035
ACCESSION NUMBER: 0001209191-16-148756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161104
FILED AS OF DATE: 20161107
DATE AS OF CHANGE: 20161107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEPHEID
CENTRAL INDEX KEY: 0001037760
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 770441625
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 904 CARIBBEAN DRIVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
BUSINESS PHONE: 4085414191
MAIL ADDRESS:
STREET 1: 904 CARIBBEAN DRIVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paterson Wayne
CENTRAL INDEX KEY: 0001640666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30755
FILM NUMBER: 161979715
MAIL ADDRESS:
STREET 1: 904 CARIBBEAN DRIVE
CITY: SUNNYVALE
STATE: X1
ZIP: 94089
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-04
1
0001037760
CEPHEID
CPHD
0001640666
Paterson Wayne
904 CARIBBEAN DRIVE
SUNNYVALE
CA
94089
1
0
0
0
Common Stock
2016-11-04
4
D
0
4500
D
0
D
Non-Qualified Stock Option (Right to Buy)
56.70
2016-11-04
4
D
0
24400
0.00
D
2022-04-28
Common Stock
24400
0
D
Non-Qualified Stock Option (Right to Buy)
36.59
2016-11-04
4
D
0
16300
0.00
D
2023-04-26
Common Stock
16300
0
D
This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest.
On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger ("Merger Agreement") with Danaher Corporation, a Delaware corporation (the "Acquirer"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer. Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the "Closing"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53.00, without interest (the "Merger Consideration").
Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor.
1/3 of the shares subject to the grant vest and become exercisable on each anniversary of the grant date, subject to the continuing service of the Reporting Person on the vesting date.
Upon the Closing, 100% of this option's vesting was accelerated and converted into the right to receive an amount of cash equal to the number of shares outstanding under the option multiplied by $53.00 minus the exercise price.
100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date.
Jacobin Zorin, Attorney-In-Fact
2016-11-07